Ledger.Open graph →

SEC Form D · filed December 4, 2015

Recursion Pharmaceuticals, LLC

Offering

$2.7M

Sold

$2.6M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SALT LAKE CITY, UT

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Dean Y. Li · Salt Lake City, UTExec · Director Christopher C. Gibson · Salt Lake City, UTExec · Director Blake C. Borgeson · Salt Lake City, UTExec · Director Julius S. Knowles · Lexington, MAExec · Director Alon S. Lazarus · Lexington, MAExec · Director Ran S. Nussbaum · Lexington, MAExec · Director Perry Fell · Salt Lake City, UTDirector Jordan A. Grayson · Orinda, CAExec · Director Neelima Shukla · Denver, COExec · Director Ryan Holoubek · Denver, COExec · Director Perry Fell · Salt Lake City, UTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗